Sergio Kaiser MD, PhD, FACC, FESC 🇧🇷🇮🇱🇷🇴🇺🇦
@pabeda1
Followers
5K
Following
35K
Media
2K
Statuses
17K
Cardiologist, Associate Prof. of Internal Medicine, Rio de Janeiro State University. Passion for preventive Cardiology, heart failure, art and classical music
Rio de Janeiro, Brasil
Joined October 2012
RT @drpablocorral: Merck Announces Positive Topline Results From the First Two Phase 3 CORALreef Trials Evaluating Enlicitide Decanoate for….
0
8
0
Published today: .Alcohol and cardiovasculsr disease: There seem to be many gaps in knowledge regarding low/moderate consumption. #cardiovascular #hypertension @SABOURETCardio @SantosGallegoMD @Hragy @RajayNarain @DrRajivsankar @rladeiraslopes
2
7
14
RT @society_eas: 📢 1 week to go – don’t miss out!.Join Professor Pablo Corral and leading experts for the EAS Advanced Course on Rare Lipid….
0
6
0
RT @society_eas: Invitation from Professor Pablo Corral.Join us for the upcoming EAS Advanced Course on Rare Lipid Disorders: Bridging Know….
0
5
0
Following #Heartfailure2025 tweets with this beautiful sunny sunday background in Copacabana! @novitskiynic @GiuseppeGalati_ @FH_Verbrugge @VerwerftJan @luisbeckdasilva
1
0
13
RT @javierrcarrio: New @society_eas #AtheroTalk episode is out!. In this episode, we talk with Prof. Noam Zelcer on the evolving field of l….
0
2
0
RT @novitskiynic: 🔥Summary of hottest trials, .trial updates and registries by day in cards below #HeartFailure2025 . @escardio @HFA_Presid….
0
13
0
#2 (Continued from 1st tweet): Any special reason for not having included finerenone? @ProfKausikRay @DLBHATTMD @mvaduganathan @hvanspall .Reference:
0
0
3
#1 Upon reading the European Consensus, I noticed that in stage 3 SMD, HFPEF management did not consider finerenone, tested for HFPEF in the FINE ARTS study with (+) results. In those pts, the RRR of the 1ary endpoint RRR was already statistically significant on the 1st month.
1
0
12
What happened with the names in the last photo? 🤷♂️, Well, here we go again: @MutazAlsabah, @SABOURETCardio !.
0
0
2
That was cool, my thanks to @society_eas !.
What happens when science meets storytelling?. At the EAS Stage, the SoMe Team explored how social media can amplify research, boost physician voices & spark real-time connections. 👉Social media isn’t just a tool — it’s part of the conversation.#EASCongress2025
0
2
14
RT @FedericaFogacci: The first human experience with MAR001, a drug targeting ANGPTL4, shows promising results. Phase 2a demonstrated a 50%….
0
5
0
🥰.
#EASCongress2025 Sergio Kaiser highlights the positive aspects to be part of #EAS and active on #SoMe ☀️
0
0
7
Short thread: #2: A few personal highlights of this amazing #EASCongress2025 @ethanjweiss @LaneyJonesRx Cezary Wojcik @ProfKausikRay Luz Clemencia Zárate @MaximaMendez15 @BNordestgaard Ximena Reyes, Angel Garcia. Where is our selfie, @DrMarthaGulati ?
2
3
15
Short thread: #1: A few personal highlights of this amazing #EASCongress2025 @PamTaubMD, Belga Skuladottir, Alberto Zambon, @MeralKayikcoglu @MaximaMendez15 @RajayNarain Fotios Barkas, @AndreZimerman
3
3
22
Thread #3: New @society_eas Consensus Statement on clinical staging to guide management of systemic metabolic disorders (Stage3 and summary).
0
2
7
Thread #3: New @society_eas Consensus Statement on clinical staging to guide management of systemic metabolic disorders (Stages 1 and 2 diagnosis and management)
1
2
5
Thread #2: New @society_eas Consensus Statement on clinical staging to guide management of systemic metabolic disorders. Data from UK biobank
1
1
3
Thread #1: New @society_eas Consensus Statement on clinical staging to guide management of systemic metabolic disordersPresented today by Stefano Romeo at #EASCongress2025 and published simultaneously at @ESC_Journals (Stage 1 and 2:Diagnosis):
1
5
21